
Anixa Biosciences ANIX
€ 2.47
-4.92%
Quartalsbericht 2025-Q4
hinzugefügt 09.03.2026
Anixa Biosciences P/CF 2011-2026 | ANIX
P/CF Jährlich Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.0144 | -0.00965 | -0.0243 | -0.0211 | -12.2 | 2.44 K | -15.4 | -16 | -7.97 | -15.5 | 20.7 | -17.1 | -14.2 | -12.7 | -32.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.44 K | -32.9 | 154 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
28.3 | $ 116.17 | 0.54 % | $ 35.3 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
19.6 | $ 128.13 | 0.2 % | $ 20.4 B | ||
|
Co-Diagnostics
CODX
|
-0.201 | $ 1.67 | - | $ 2.22 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Lantheus Holdings
LNTH
|
13.1 | $ 84.55 | 0.26 % | $ 5.71 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 416.87 | 1.54 % | $ 12 B | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 25.33 | 3.56 % | $ 704 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.56 | 0.33 % | $ 20 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 21.59 | 1.7 % | $ 1.15 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 7.13 | 1.13 % | $ 298 M | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 52.73 | 0.01 % | $ 2.68 B | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 16.0 | -1.9 % | $ 484 M | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 468.52 | -0.22 % | $ 177 B | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.64 | -1.51 % | $ 61.9 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
Twist Bioscience Corporation
TWST
|
-32.8 | $ 60.4 | -0.89 % | $ 3.61 B | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 172.02 | 1.33 % | $ 8.53 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
Guardant Health
GH
|
-72.7 | $ 90.04 | 1.27 % | $ 11.3 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
1.26 | $ 1.91 | -3.29 % | $ 8.45 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 9.51 | -0.37 % | $ 2.06 B | ||
|
Biomerica
BMRA
|
-1.87 | $ 2.16 | 0.86 % | $ 4.96 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 17.09 | -0.81 % | $ 383 M | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 100.76 | -1.38 % | $ 8.31 B | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 263.91 | 0.06 % | $ 22 B | ||
|
Celcuity
CELC
|
-35 | $ 122.87 | 1.52 % | $ 5.75 B | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
NeoGenomics
NEO
|
284 | $ 8.6 | 3.68 % | $ 1.1 B | ||
|
Myriad Genetics
MYGN
|
227 | $ 4.76 | -0.31 % | $ 441 M | ||
|
Natera
NTRA
|
-12.3 | $ 205.87 | 1.04 % | $ 20.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
12.4 | $ 196.59 | 0.19 % | $ 21.8 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
PerkinElmer
PKI
|
22.5 | - | -0.91 % | $ 14.7 B |